Nuclea Biotechnologies' Series B - II Round

Nuclea Biotechnologies raised a round of funding on October 11, 2011.

Nuclea Biotechnologies is a healthcare company dedicated to the development and commercialization of clinical diagnostic assays identifying gene and protein expression profiles characteristic of an in…

Articles about Nuclea Biotechnologies' Series B - II Round: